28 July 1986
INTERIM COMMERCIAL ITEM DESCRIPTION
PLASMA PROTEIN FRACTION, USP, HEAT-TREATED
The General Services Administration has authorized the use of this Interim Commercial Item Description which was developed by DLA, Defense Personnel Support Center, Directorate of Medical Materiel, DPSC-ATT, 2800 South 20th Street, Philadelphia, PA 19101, based upon currently available technical information.
Shall be Plasma Protein Fraction, USP, Heat-Treated.
Shall be in accordance with the requirements of the USP.
Shall contain 5 percent protein within the applicable assay limits for the solution.
Sizes 1 and 2, shall be supplied with a commercially available sterile intravenous set with inline filter and a 19 or 20 gage needle compatible for use with the container of the solution.
Samples of the final, filled immediate containers shall be submitted as follows:
The quality assurance representative, when inspection is at source, or the contractor, when inspection is a destination, shall send the following by the fastest route directly to:
Department of Biologic Research
Division of Communicable Disease and Immunology
Walter Reed Army Institute of Research, Bldg 40
ATTN: Mr. Calvin Powell, Room 2022
Washington, DC 20307-5100
DISTRIBUTION STATEMENT A. Approved for public release; distribution is unlimited.
For Parts Inquires submit RFQ to Parts Hangar, Inc.
© Copyright 2015 Integrated Publishing, Inc.
A Service Disabled Veteran Owned Small Business